Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: Nationwide survey results over 30 years

Multiple Sclerosis

Volumn 15, Issue 2, 2009, Pages 159-173

  Osoegawa, M ^a   Kira, Jun Ichi ^a   Fukazawa, T ^b   Fujihara, K ^c   Kikuchi, S ^d   Matsui, M ^e   Kohriyama, T ^f   Sobue, G ^g   Yamamura, T ^h   Itoyama, Y ^c   Saida, T ⁱ   Sakata, K ^j   Ochi, H ^a   Matsuoka, T ^a   Kuroiwa, Yoshigoro ^a   Igata, Akihiro ^k   Nishitani, Hiroshi ⁱ   Chiba, Susumu ^l   Fujii, Yoshitaka ^m   Furukawa, Susumu ⁿ   Hara, Hideo ^o   Hara, Toshirou ^p   Hisanaga, Kinya ^q   Ikeda, Shu Ichi ^r   Izumo, Shuji ^k   Kaji, Ryuji ^s   Kanda, Takashi ⁿ   Koh, Shosei ^r   Kusunoki, Susumu ^t   Kuwabara, Satoshi ^u   Matsuo, Hidenori ^v   Mizusawa, Hidehiro ^w   Nakamura, Tatsufumi ^x   Nomura, Kyoichi ^y   Ogino, Mieko ^z   Ohara, Yoshiro ^e   Osame, Mitsuhiro ^k   Ota, Kohei ^aa   Shimizu, Jun ^ab   Suzumura, Akio ^ac   Tabira, Takeshi ^o   Tanaka, Keiko ^ad   Tanaka, Masami ^ae   Yoneda, Makoto ^af   Yoshikawa, Hiroaki ^ag   Yuki, Nobuhiro ^ah   more..

^a KYUSHU UNIVERSITY   (Japan)

^b Nishimaruyama Hospital   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d HOKKAIDO MEDICAL CENTER   (Japan)

^e KANAZAWA MEDICAL UNIVERSITY   (Japan)

^f HIROSHIMA UNIVERSITY   (Japan)

^g NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

ⁱ UTANO NATIONAL HOSPITAL   (Japan)

^j IWATE MEDICAL UNIVERSITY   (Japan)

^k KAGOSHIMA UNIVERSITY   (Japan)

^l SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^m NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

ⁿ YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^o NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^p KYUSHU UNIVERSITY   (Japan)

^q MIYAGI NATIONAL HOSPITAL   (Japan)

^r SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^s UNIVERSITY OF TOKUSHIMA   (Japan)

^t KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^u CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^v NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^w TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^x NAGASAKI UNIVERSITY   (Japan)

^y SAITAMA MEDICAL UNIVERSITY   (Japan)

^z KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^aa TOKYO UNIVERSITY OF SCIENCE   (Japan)

^ab UNIVERSITY OF TOKYO   (Japan)

^ac NAGOYA UNIVERSITY   (Japan)

^ad NIIGATA UNIVERSITY   (Japan)

^ae NISHI NIIGATA CHUO NATIONAL HOSPITAL   (Japan)

^af UNIVERSITY OF FUKUI   (Japan)

^ag KANAZAWA UNIVERSITY   (Japan)

^ah DOKKYO MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

Epidemiology; Japanese; Latitude; Magnetic resonance imaging; Multiple sclerosis; Optic spinal

Indexed keywords

ADULT; ARTICLE; BRAIN DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENVIRONMENTAL FACTOR; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; JAPAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OPTIC NERVE ATROPHY; OPTIC NERVE DISEASE; PHENOTYPIC VARIATION; PREVALENCE; QUADRIPLEGIA; SPINAL CORD DISEASE; VISUAL IMPAIRMENT;

ADULT; AGE DISTRIBUTION; AGE OF ONSET; ASIAN CONTINENTAL ANCESTRY GROUP; CULTURE; EMIGRATION AND IMMIGRATION; ENVIRONMENT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GEOGRAPHY; HEALTH SURVEYS; HUMANS; JAPAN; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PHENOTYPE; PREVALENCE;

EID: 59349115918     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508098372     Document Type: Article

References (53)

1. Compston A Coles A. Multiple sclerosis. Lancet 2002; 359: 1221-1231.
2. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2003; 2: 117-127.
3. Okinaka S Tsubaki T Kuroiwa Y Toyokura Y Imamura Y Yoshikawa M. Multiple sclerosis and allied diseases in Japan. Clinical characteristics. Neurology 1958; 8: 756-763.
4. Shibasaki H Kuroiwa Y. Clinical studies of multiple sclerosis in Japan. II. Are its clinical characteristics changing? Neurology 1973; 23: 618-622.
5. Kira J Kanai T Nishimura Y. Western versus Asian types of multiple sclerosis: Immunogenetically and clinically distinct disorders. Ann Neurol 1996; 40: 569-574.
6. Lennon VA Wingerchuk DM Kryzer TJ. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.
7. Nakashima I Fujihara K Miyazawa I. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006; 77: 1073-1075.
8. Matsuoka T Matsushita T Kawano Y. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007; 130: 1206-1223.
9. Weinshenker BG Wingerchuk DM Nakashima I Fujihara K Lennon VA. OSMS is NMO, but not MS: Proven clinically and pathologically. Lancet Neurol 2006; 5: 110-111.
10. Kikuchi S Fukazawa T. "OSMS is NMO, but not MS": Confirmed by NMO-IgG? Lancet Neurol 2005; 4: 594-595.
11. Compston A. Complexity and heterogeneity of demyelinating disease. Brain 2007; 130: 1178-1180.
12. Osuntokun BO. The pattern of neurological illness in tropical Africa. Experience at Ibadan, Nigeria. J Neurol Sci 1971; 12: 417-442.
13. Cree BA Khan O Bourdette D. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology 2004; 63: 2039-2045.
14. Compston A. Genetic epidemiology of multiple sclerosis. J Neurol Neurosurg Psychiatry 1997; 62: 553-561.
15. Kurtzke JF Kurland LT Goldberg ID. Mortality and migration in multiple sclerosis. Neurology 1971; 21: 1186-1197.
16. Detels R Visscher BR Haile RW Malmgren RM Dudley JP Coulson AH. Multiple sclerosis and age at migration. Am J Epidemiol 1978; 108: 386-393.
17. Elian M Nightingale S Dean G. Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies. J Neurol Neurosurg Psychiatry 1990; 53: 906-911.
18. Dean G Elian M. Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry 1997; 63: 565-568.
19. Hammond SR English DR McLeod JG. The age-range of risk of developing multiple sclerosis: Evidence from a migrant population in Australia. Brain 2000; 123: 968-974.
20. Sánchez JL Palacio LG Uribe CS. Clinical features of multiple sclerosis in a genetically homogeneous tropical population. Mult Scler 2001; 7: 227-229.
21. Cabre P Signate A Olindo S. Role of return migration in the emergence of multiple sclerosis in the French West Indies. Brain 2005; 128: 2899-2910.
22. Alvarado-de la Barrera C Zúňiga-Ramos J Ruiiz-Morales JA Estaňol B Granados J Llorente L. HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis. Neurology 2000; 55: 1897-1900.
23. Kuroiwa Y Igata A Itahara K Koshijima S Tsubaki T. Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1,084 cases. Neurology 1975; 25: 845-851.
24. Shibasaki H Kubo N Nishitani H Saida T Ohno Y Fukuyama Y. Nationwide survey of multiple sclerosis in Japan: Reappraisal of clinical features. J Trop Geo Neurol 1992; 2: 73-82.
25. Miura K Nakagawa H Morikawa Y. Epidemiology of idiopathic cardiomyopathy in Japan: Results from a nationwide survey. Heart 2002; 87: 126-130.
26. Schumacher GA Beebe GW Kibler RF. Problems of experimental trials of therapy in multiple sclerosis: Report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci 1965; 122: 552-568.
27. McDonald WI Compston A Edan G. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
28. Yamasaki K Horiuchi I Minohara M. HLA-DPB1*0501-associated opticospinal multiple sclerosis: Clinical, neuroimaging and immunogenetic studies. Brain 1999; 122: 1689-1696.
29. Hashimoto S Fukutomi K Nagai M. Response bias in the nationwide epidemiological survey of an intractable disease in Japan. J Epidemiol 1991; 1: 27-30.
30. Hashimoto S Fukutomi K Nagai M. A method of interval estimation for number of patients in the nationwide epidemiological survey on intractable diseases. Jpn J Public Health 1991; 38: 880-883 [in Japanese].
31. Kurtzke JF. Rating neurologic impaiment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
32. Barkhof F Filippi M Miller DH. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059-2069.
33. Saida T Tashiro K Itoyama Y Sato T Ohashi Y Zhao Z. Interferon beta-1b is effective in Japanese RRMS patients: A randomized, multicenter study. Neurology 2005; 64: 621-630.
34. Houzen H Niino M Kikuchi S. The prevalence and clinical characteristics of MS in northern Japan. J Neurol Sci 2003; 211: 49-53.
35. Itoh T Aizawa H Hashimoto K. Prevalence of multiple sclerosis in Asahikawa, a city in northern Japan. J Neurol Sci 2003; 214: 7-9.
36. Noonan CW Kathman SJ White MC. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 2002; 58: 136-138.
37. Barnett MH Williams DB Day S Macaskill P McLeod JG. Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: A 35-year study. J Neurol Sci 2003; 213: 1-6.
38. Wallin MT Page WF Kurtzke JF. Multiple sclerosis in US veterans of the Vietnam era and later military service: Race, sex, and geography. Ann Neurol 2004; 55: 65-71.
39. Orton S-M Herrera B Yee IM Valdar W Ramagopalan SV Sadovnic AD.; for the Canadian Collaborative Study Group. Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurol 2006; 5: 932-936.
40. Cocco E Sardu C Lai M Spinicci G Contu P Marrosu MG. Anticipation of age at onset in multiple sclerosis: A Sardinian cohort study. Neurology 2004; 62: 1794-1798.
41. Marrosu MG Cocco E Lai M Spinicci G Pischedda MP Contu P. Patietns with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: A cohort study. Lancet 2002; 359: 1461-1465.
42. Kennedy J O'Connor P Sadovnick AD Perara M Yee I Banwell B. Age at onset of multiple sclerosis may be influenced by place of residence during childhood rather than ancestry. Neuroepidemiology 2006; 26: 162-167.
43. Tanaka K Tani T Tanaka M. Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler 2007; 13: 850-855.
44. Kira J Yamasaki K Horiuchi I Ohyagi Y Taniwaki T Kawano Y. Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan. J Neurol Sci 1999; 166: 53-57.
45. Nakashima I Fujihara K Takase S Itoyama Y. Decrease in multiple sclerosis with acute transverse myelitis in Japan. Tohoku J Exp Med 1999; 188: 89-94.
46. Wingerchuk DM Hogancamp WF O'Brien PC Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-1114.
47. Tartaglino LM Friedman DP Flanders AE Lublin FD Knobler RL Liem M. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 1995; 195: 725-732.
48. Su J-J Osoegawa M Minohara M. Upregulation of vascular growth factors in multiple sclerosis: Correlation with MRI findings. J Neurol Sci 2006; 243: 21-30.
49. Minohara M Matsuoka T Li W. Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: Positive correlation with disease severity. J Neuroimmunol 2006; 178: 156-160.
50. Bot JC Barkhof F Polman CH. Spinal cord abnormalities in recently diagnosed MS patients: Added value of spinal MRI examination. Neurology 2004; 62: 226-233.
51. Department of Environmental Health, Hokkaido Prefecture Government. The 2006 Hokkaido Ainu Current Living Conditions Survey Report. 2006 [In Japanese].
52. Bannai M Ohashi J Harihara S. Analysis of HLA genes and haplotypes in Ainu (from Hokkaido, northern Japan) supports the premise that they descent from Upper Paleolithic populations of East Asia. Tissue Antigens 2000; 55: 128-139.
53. Tajima A Hayami M Tokunaga K. Genetic origins of the Ainu inferred from combined DNA analyses of maternal and paternal lineages. J Hum Genet 2004; 49: 187-193.